| ID | Name | CAS | Properties |
MW (g/mol) |
| 20-940-5 |
N,N-Dimethyl-N'-(3-bromophenyl)-pivalamidine
|
|
3 | 283.21 |
| 21-025-0 |
Silane, dimethyl(2,2,2-trichloroethoxy)hexyloxy-
|
|
3 | 307.72 |
| 21-193-4 |
4-Heptanone, 2,4,6-trichlorophenyl hydrazone
|
|
3 | 307.65 |
| 21-231-1 |
3«beta»,5«alpha»-Tetrahydrodeoxycorticosterone, MO-TMS
|
|
3 | 507.90 |
| 21-323-9 |
Butane, 2-azido-2,3,3-trimethyl-
|
51677-41-9 |
3 | 141.21 |
| 21-346-4 |
2,4(1H,3H)-Pteridinedione, 8-methyl-
|
13300-38-4 |
3 | 178.15 |
| 21-658-8 |
2-Butanone, 3-methylthio, PFBO # 2
|
|
3 | 313.29 |
| 21-967-5 |
1,4-Bis(triallylammonium)butene-2-dibromide
|
|
3 | 488.35 |
| 22-039-4 |
4-Tert-butyl-2-chlorophenyl methyl dimethylamidophosphate
|
14163-82-7 |
3 | 305.74 |
| 22-130-2 |
Thymidine, 3'-O-TBDMS, 5'-O-TMS
|
|
3 | 428.67 |
| 22-287-9 |
N,N-Dimethyl-N'-(4-chlorophenyl)-pivalamidine
|
|
3 | 238.76 |
| 22-298-7 |
5-«alpha»-Pregnan-11,20-dione, MO
|
|
3 | 374.56 |
| 22-580-3 |
4-Fluoro-2-methoxyphenol, tert-butyldimethylsilyl ether
|
|
3 | 256.39 |
| 22-584-9 |
Silane, dimethyl(3,4,5-trichlorophenoxy)hexyloxy-
|
|
3 | 355.76 |
| 22-776-6 |
1,2-Naphthalenedione, 1-[(4-methoxyphenyl)hydrazone]
|
|
3 | 278.31 |
| 22-802-6 |
N,N-Dimethyl-N'-(4-bromophenyl)-propionamidine
|
|
3 | 255.15 |
| 22-880-0 |
Silane, diethyl(3-methylpent-2-yloxy)undecyloxy-
|
|
3 | 358.68 |
| 23-022-1 |
5-ethyl-4-methyl-2-pentyl-thiazole
|
|
3 | 197.34 |
| 23-242-7 |
Clomethiazole M (des-Cl, di-OH, -H2O)
|
|
3 | 141.19 |
| 23-493-9 |
Silane, diethyl(2-methylpent-3-yloxy)pentyloxy-
|
|
3 | 274.52 |
| 23-829-6 |
Formamidine, 3,3-hexamethyleno-1-(4-bromophenyl)
|
|
3 | 281.20 |
| 23-927-7 |
Butanedioic acid, methyl-, bis(tert-butyldimethylsilyl) ester
|
98830-33-2 |
3 | 360.64 |
| 24-107-6 |
«beta»-Alanine, N-(2-furoyl)-, isohexyl ester
|
|
3 | 267.32 |
| 24-373-1 |
2-(M-phenoxyphenoxy)-3-(2-trimethylsilylethyl) pyrazine
|
|
3 | 364.51 |
| 24-684-6 |
Silane, dimethyl(3,4,5-trichlorophenoxy)undecyloxy-
|
|
3 | 425.90 |
| 24-792-6 |
L-(-)-Fucose, tetrakis(trifluoroacetate), benzyloxime (isomer 1)
|
|
3 | 653.33 |
| 24-813-2 |
Silane, diethyl(3-methylpent-2-yloxy)octyloxy-
|
|
3 | 316.60 |
| 24-999-7 |
(1R2S)-Norephedrine, N-(2-phenylbutanoyl)-O-TMS
|
|
3 | 369.57 |
| 25-101-1 |
trans-2-Dodecen-1-ol, picolinyloxydimethylsilyl ether
|
|
3 | 349.58 |
| 25-484-7 |
1,2-Naphthalenedione, 1-[(4-methylphenyl)hydrazone]-
|
64022-28-2 |
3 | 262.31 |
| 25-488-3 |
Nefazodone-M (HO-ethyl-desamino-HO-) AC
|
|
3 | 391.42 |
| 25-489-2 |
1H-1,2,4-Triazole, 1-methyl-
|
|
3 | 83.09 |
| 25-542-2 |
Poligodial + Phe (methyl ester) adduct, (R)
|
|
3 | 377.52 |
| 25-609-8 |
Trans-3-benzoyl-4-phenyl-1-methylpiperdine
|
116595-02-9 |
3 | 279.38 |
| 25-728-6 |
3-sec-Butyl-2-methoxy-6-methylpyrazine
|
|
3 | 180.25 |
| 25-895-1 |
Methanimine, 1-(4-morpholino), N-(3-methoxyphenyl)
|
|
3 | 220.27 |
| 26-314-4 |
Isonipecotic acid, N-(5-chlorovaleryl)-, isohexyl ester
|
|
3 | 331.88 |
| 26-399-1 |
1,3-dimethylpyrrolo(1,2-a)pyrazine
|
|
3 | 146.19 |
| 26-405-3 |
Cystathionine, N,N'-bis(dimethylaminomethylene)-, dimethyl ester
|
|
3 | 360.47 |
| 26-619-6 |
Phosphorous acid, cyclic o-phenylene-, isobutyl ester
|
4591-39-3 |
3 | 212.18 |
| 26-814-9 |
Isonipecotic acid, N-(4-ethylbenzoyl)-, isohexyl ester
|
|
3 | 345.48 |
| 27-082-1 |
D-(+)-Glucose, pentakis(trifluoroacetate), methyloxime (syn)
|
|
3 | 689.24 |
| 27-094-8 |
N,N-Dimethyl-N'-octyl-p-chlorobenzamidine
|
|
3 | 294.86 |
| 27-430-4 |
2-Methyl-3-heptanone, PFBO # 2
|
|
3 | 323.30 |
| 27-464-7 |
Isonipecotic acid, N-(3-phenylpropionyl)-, isobutyl ester
|
|
3 | 317.43 |
| 27-613-1 |
(1S2S)-Ephedrine, N-(2-phenylbutanoyl)-O-TMS
|
|
3 | 383.61 |
| 27-764-4 |
Benzeneacetic acid, «alpha»-[(trimethylsilyl)oxy]-, trimethylsilyl ester
|
2078-19-5 |
3 | 296.51 |
| 28-139-7 |
D-(+)-Talose, pentakis(trifluoroacetate), methyloxime (syn)
|
|
3 | 689.24 |
| 28-197-3 |
N,N-Dimethyl-N'-hexyl-p-chlorobenzamidine
|
|
3 | 266.81 |
| 28-600-4 |
Benzylidenimine,n-(2,2-diethoxyethyl)-o-hydroxy-
|
|
3 | 237.30 |
| 28-749-0 |
Californine-M, (demethylene-methyl-) isomer-2 AC
|
|
3 | 367.40 |
| 29-138-7 |
Silane, diethyl(4-methylpent-2-yloxy)octadecyloxy-
|
|
3 | 456.86 |
| 29-255-7 |
P-phenyl azo carbanilic acid, linalyl ester
|
|
3 | 377.49 |
| 29-766-0 |
2,3,4,6,9-pentabromo-dibenzofuran
|
|
3 | 562.67 |
| 29-827-2 |
Methyl 2,4-dimethyl-3-thienyl disulfide
|
|
3 | 158.28 |
| 29-864-1 |
Silane, dimethyl(3,4,5-trichlorophenoxy)hexadecyloxy-
|
|
3 | 496.03 |
| 30-174-5 |
7H-Dibenzo-8,9,10,11-tetrahydro-
|
|
3 | 270.37 |
| 30-493-1 |
2-Fluoro-5-nitrobenzyl alcohol, benzyldimethylsilyl ether
|
|
3 | 319.41 |
| 30-509-3 |
Thymidine, 3'-O-acetyl, 5'-O-TBDMS
|
56070-42-9 |
3 | 398.53 |
| 30-633-5 |
Glycine, N-(4-hydroxybenzoyl)-, bis(trimethylsilyl) deriv.
|
|
3 | 339.54 |
| 30-943-1 |
Isonipecotic acid, N-(4-ethylbenzoyl)-, isobutyl ester
|
|
3 | 317.43 |
| 31-015-0 |
O-isobutyl-S-(1,1-difluoroethyl)-dithioethylphosphonate
|
|
3 | 262.33 |
| 31-032-1 |
7-acetyl-9-(2,3-dimethylbutyryl) retronecine
|
|
3 | 295.37 |
| 31-056-5 |
5-ethyl-4-methyl-2-nonyl-thiazole
|
|
3 | 253.45 |
| 31-237-4 |
Thymidine, 3'-O-TFA, 5'-O-TBDMS
|
|
3 | 452.50 |
| 31-332-8 |
Nomifemsine M(HO), diacetylated, isomer # 2
|
|
3 | 338.40 |
| 31-481-3 |
Isonipecotic acid, N-(3-methoxybenzoyl)-, isohexyl ester
|
|
3 | 347.45 |
| 31-535-3 |
N,N-Dimethyl-N'-(3-bromophenyl)-isobutyramidine
|
|
3 | 269.18 |
| 31-842-2 |
N,N-Dimethyl-N'-(4-bromophenyl)-pivalamidine
|
|
3 | 283.21 |
| 31-994-4 |
Benzimidazole, 5-chloro-6-nitro-2-(trifluoromethyl)-
|
6609-40-1 |
3 | 265.58 |
| 32-007-8 |
O-(1,1-Difluoro-2-chloroethyl)-phosphorothiodichloridate
|
|
3 | 249.43 |
| 32-029-4 |
Ramipril desethyl - H2O Me (Ramiprilate- H2O Me)
|
|
3 | 383.49 |
| 32-427-2 |
Silane, diphenyldi(pent-4-en-2-yloxy)-
|
|
3 | 352.55 |
| 32-756-7 |
Cystathionine, N,N'-bis(dimethylaminomethylene)-, diethyl ester
|
|
3 | 388.52 |
| 32-921-3 |
2-Methyl-3',4-dichloro-4'-benzyloxyazobezene
|
88578-29-4 |
3 | 371.26 |
| 33-395-7 |
Enalapril desethyl - H2O, Me (Enalaprilate - H2O, Me)
|
|
3 | 344.40 |
| 33-458-7 |
Methanimine, 1-(4-morpholino), N-(4-bromophenyl)
|
|
3 | 269.14 |
| 33-572-0 |
1,5,6-trimethyl-2(1H)-pyrazinone
|
|
3 | 138.17 |
| 33-716-0 |
1-Phenyl-4,4-dimethyl-3-pyrazolidone
|
2654-58-2 |
3 | 190.24 |
| 33-867-3 |
Methanimine, 1-(1-piperidinyl), N-(3-bromophenyl)
|
|
3 | 267.17 |
| 33-924-9 |
Silane, diethyl(2-methylpent-3-yloxy)octyloxy-
|
|
3 | 316.59 |
| 33-935-7 |
Silane, diethyldecyloxy(3,3-dimethylbut-2-yloxy)-
|
|
3 | 344.65 |
| 34-264-1 |
Quinapril desethyl - H2O Me (Quinaprilate - H2O Me)
|
|
3 | 406.48 |
| 34-397-4 |
N,N-Dimethyl-N'-(4-bromophenyl)-isobutyramidine
|
|
3 | 269.19 |
| 34-783-5 |
Isonipecotic acid, N-(2-furoyl)-, undecyl ester
|
|
3 | 377.52 |
| 35-022-8 |
(N-pentylsulfonyl) methyl-4-thiazoline-2-thione
|
|
3 | 265.42 |
| 35-038-1 |
2,3-DICYANO-5-METHYL-6-PHENYLPYRAZINE
|
|
3 | 220.24 |
| 35-092-1 |
DL-2-fluorophenylglycine, N-dimethylaminomethylene-, methyl ester
|
|
3 | 238.26 |
| 35-264-0 |
2-AMINO-4-HYDROXYPTERIDINE-6-CARBOXYLIC ACID
|
|
3 | 207.15 |
| 35-371-1 |
2-Ethylhexenal-2, 2,4-dinitrophenyl hydrazone
|
|
3 | 306.32 |
| 35-456-7 |
Isonipecotic acid, N-(4-butylbenzoyl)-, isohexyl ester
|
|
3 | 373.53 |
| 35-897-8 |
Californine-M, (demethylene-methyl-) isomer-1 AC
|
|
3 | 367.40 |
| 36-003-8 |
2-(3'-hydroxy,4'-methoxyphenylethyl)-4-methoxyquinoline
|
|
3 | 309.36 |
| 36-018-2 |
o-Ethyl S-3-(dimethylamino)propyl methylphosphonothiolate
|
|
3 | 225.29 |
| 36-061-4 |
Phosphoramidocyanidic acid, N,N-dimethyl-, isopropyl ester
|
63815-55-4 |
3 | 176.15 |
| 36-368-4 |
5-Methoxy-2,4-dimethyl-1H-indole
|
|
3 | 175.23 |
| 36-386-4 |
Silane, dimethyl(dimethyl(2-decyloxy)silyloxy)propoxy-
|
|
3 | 348.67 |
| 36-516-9 |
Isonipecotic acid, N-(2-furoyl)-, nonyl ester
|
|
3 | 349.47 |
| 36-552-9 |
2,4,5-Trichlorophenol, tert-butyldimethylsilyl ether
|
|
3 | 311.71 |
| 36-824-7 |
N,N-Dimethyl-N'-(3-chlorophenyl)-isobutyramidine
|
|
3 | 224.73 |
|
« Previous Results
Next Results »
|